Members |
targetComponentId |
Hemarthrosis of other site, NEC |
Hemarthrosis |
Hematological agents adverse reaction |
Adverse reaction to drug |
Hematoside |
GM3-ganglioside |
Hematuria NOS |
Blood in urine |
Hemoglobin F-Calluna |
Hemoglobin F-Heather |
Hemoglobin F-Iwata |
Hemoglobin F-Minoo |
Hemoglobin F-Kuala Lumpur |
Hemoglobin F-Urumqi |
Hemoglobin F-Siena |
Hemoglobin F-Carlton |
Hemoglobin F-Yamaguchi |
Hemoglobin F-Marietta |
Hemoglobin J-Kaohslung |
Haemoglobin J-Kaohsiung |
Hemoglobin J-Nayanza |
Haemoglobin J-Nyanza |
Hemoglobin S |
Hemoglobin S |
Hemoglobin S disease |
Sickle cell-hemoglobin SS disease |
Hemoglobin S disease with crisis |
Hemoglobin SS disease with crisis (disorder) |
Hemoglobin S disease without crisis |
Hemoglobin SS disease without crisis (disorder) |
Hemoglobin very high |
Hemoglobin above reference range |
Hemoglobin very low |
Hemoglobin below reference range (finding) |
Hemolysis |
Hemolysis |
Hemolytic disease due to other isoimmunization, NEC |
Hemolytic disease of the newborn due to non-ABO, non-Rh isoimmunization |
Hemolytic uremic syndrome |
Hemolytic uremic syndrome |
Hemoquant feces |
Evaluation of stool specimen |
Hemorrhage due to any device, implant AND/OR graft |
Bleeding |
Hemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
Hemorrhagic nephroso-nephritis |
Hemorrhagic fever with renal syndrome (disorder) |
Hemorrhoidectomy by injection |
Destruction of hemorrhoids by sclerotherapy |
Hemostasis of unspecified organ |
Control of hemorrhage |
Hepadnavirus |
Family Hepadnaviridae (organism) |
Heparin 100unt |
Product containing heparin (medicinal product) |
Heparin 10unt |
Product containing heparin (medicinal product) |
Heparin cofactor I |
Antithrombin III |
Heparin sodium 100 unt/mL solution |
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection |
Heparin sodium 1000iu/sodium chloride 0.9% infusion solution ampule |
Product containing only heparin in parenteral dose form (medicinal product form) |
Heparin sodium 10u/mL injection solution ampule |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
Heparin sodium 10unt/mL solution |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
Heparin sodium in 0.9% sodium chloride 1000iu/500mL infusion |
Product containing only heparin in parenteral dose form (medicinal product form) |
Hepatectomy |
Excision of liver (procedure) |
Hepatic colic |
Biliary colic |
Hepatitis |
Inflammatory disease of liver |
Hepatitis B group virus |
Genus Orthohepadnavirus (organism) |
Hepatitis B immunoglobulin 1000iu powder for injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis B immunoglobulin 200iu powder for injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis B immunoglobulin 500iu powder for injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis B screening test |
Hepatitis B screening |
Hepatitis B screening test |
Hepatitis B screening |
Hepatitis B screening test |
Hepatitis B screening |
Hepatitis b immune globulin 217u injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis b immune globulin 312units/mL injection solution 1mL vial |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
Hepatitis b immune globulin 312units/mL injection solution 5mL vial |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
Hepatitis caused by Toxoplasma |
Hepatitis caused by Toxoplasma gondii |
Hepatitis non-A non-B |
Viral hepatitis |
Hepatitis panel |
Hepatitis panel measurement |
Hepatocerebral encephalopathy |
Hepatic encephalopathy |
Herbaspirillum rubrisualbicans |
Herbaspirillum rubrisubalbicans (organism) |
Hereditary disease |
Hereditary disease |
Hereditary endotheliopathy, retinopathy, nephropathy, stroke syndrome |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
Hereditary malignant neuroendocrine neoplasm of small intestine |
Hereditary well-differentiated neuroendocrine tumor of small intestine (disorder) |
Hereditary methemoglobinemia, enzymatic type |
Autosomal recessive congenital methemoglobinemia (disorder) |
Hereditary nephrogenic diabetes insipidus |
Hereditary vasopressin resistance |
Hereditary nonspherocytic hemolytic anemia due to aldolase A deficiency |
Glycogen storage disease due to aldolase A deficiency (disorder) |
Hereditary nonspherocytic hemolytic anemia due to reduced nicotinamide adenine dinucleotide-methemoglobin reductase deficiency |
Autosomal recessive congenital methemoglobinemia (disorder) |
Hereditary progressive muscular dystrophy |
Muscular dystrophy |
Hereditary sensory-motor neuropathy, type V |
Hereditary motor and sensory neuropathy type 5 (disorder) |
Hereditary site-specific ovarian cancer syndrome |
Hereditary breast and ovarian cancer syndrome (disorder) |
Hereditary thrombocytopenia NEC |
Hereditary thrombocytopenic disorder (disorder) |
Hereditary vascular retinopathy |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
Hermansky-Pudlack syndrome |
Hermansky-Pudlak syndrome |
Hermaphroditism |
Ovotesticular disorder of sex development |
Hermaphroditism |
Ovotesticular disorder of sex development |
Heroin - non-pharmaceutical |
Diamorphine (substance) |
Herpailurus yaguarondi |
Puma yagouaroundi (organism) |
Herpes simplex with other specified complications |
Herpes simplex with complication |
Herpes simplex with unspecified complications |
Herpes simplex with complication |
Herpes zoster with complication |
Herpes zoster |
Herpes zoster with ophthalmic complication |
Herpes zoster ophthalmicus |
Herpes zoster with other complications |
Herpes zoster |
Herpes zoster with other nervous system complications |
Herpes zoster with nervous system complication |
Herpes zoster with other ophthalmic complication |
Herpes zoster ophthalmicus |
Herpes zoster with other specified complication |
Herpes zoster |
Herpes zoster with other specified complication NOS |
Herpes zoster |
Herpes zoster with unspecified complication |
Herpes zoster |
Herring - dietary |
Herring (substance) |
Hetastarch 6% |
Hetastarch 60 mg/mL solution for injection |
Hetastarch 6% infusion solution bottle |
Hetastarch 60 mg/mL solution for injection |
Hetastarch 6g liquid |
Hetastarch 60 mg/mL solution for injection |
Hetastarch allergy |
Non-allergic hypersensitivity to hetastarch (finding) |
Heteropagus |
Asymmetrical conjoined twins (disorder) |
Hexahydrophtalic anhydrid specific extract |
Hexahydrophthalic anhydride (substance) |
Hexamethylene diisocyanate specific extract |
Hexamethylene diisocyanate (substance) |
Hexastarch 6% infusion solution bottle |
Product containing precisely hexastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Hexosyltransferase |
Hexosyltransferase |
Hickman catheter, device |
Central venous catheter |
Hickman line injection |
Central venous catheter injection |
Hickman line tip |
Central venous catheter tip |
High risk non proliferative diabetic retinopathy |
Severe nonproliferative retinopathy due to diabetes mellitus (disorder) |
High risk of |
High risk of |
Hind brain contusion with open intracranial wound, unspecified state of consciousness |
Contusion of hindbrain with open intracranial wound (disorder) |
Hind brain contusion with open intracranial wound, with concussion, unspecified |
Contusion of hindbrain with open intracranial wound (disorder) |
Hind brain contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of hindbrain with open intracranial wound (disorder) |
Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
Hip DXA scan |
Dual energy X-ray absorptiometry of hip (procedure) |
Hip dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of hip (procedure) |